Dynavax Technologies (LTS:0IDA) Total Assets : $986.6 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dynavax Technologies Total Assets?

Dynavax Technologies's Total Assets for the quarter that ended in Mar. 2024 was $986.6 Mil.

During the past 12 months, Dynavax Technologies's average Total Assets Growth Rate was -17.30% per year. During the past 3 years, the average Total Assets Growth Rate was 10.60% per year. During the past 5 years, the average Total Assets Growth Rate was 36.50% per year. During the past 10 years, the average Total Assets Growth Rate was 45.90% per year.

During the past 13 years, Dynavax Technologies's highest 3-Year average Total Assets Growth Rate was 129.50%. The lowest was -56.20%. And the median was 19.90%.

Total Assets is connected with ROA %. Dynavax Technologies's annualized ROA % for the quarter that ended in Mar. 2024 was -3.52%. Total Assets is also linked to Revenue through Asset Turnover. Dynavax Technologies's Asset Turnover for the quarter that ended in Mar. 2024 was 0.05.

Dynavax Technologies Total Assets Historical Data

The historical data trend for Dynavax Technologies's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynavax Technologies Total Assets Chart

Dynavax Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

279.07

353.27

1,039.25

985.85

997.10

Dynavax Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															969.92	936.43	972.93	997.10	986.57

Dynavax Technologies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Dynavax Technologies's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	622.072	+	375.024
	=	997.1

Dynavax Technologies's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	618.48	+	368.085
	=	986.6

Dynavax Technologies (LTS:0IDA) Total Assets Explanation

Total Assets is connected with ROA %.

Dynavax Technologies's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-34.884	/	( (997.096	+	986.565)	/ 2 )
	=	-34.884	/	991.8305
	=	-3.52 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Dynavax Technologies's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	50.79	/	( (997.096	+	986.565)	/ 2 )
=	50.79	/	991.8305
=	0.05

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Dynavax Technologies Total Assets Related Terms

Thank you for viewing the detailed overview of Dynavax Technologies's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Dynavax Technologies (LTS:0IDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dynavax Technologies Corp (LTS:0IDA) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

DVAX:USA DYF1:Germany

Address

2100 Powell Street, Suite 900, Emeryville, CA, USA, 94608

Website

https://www.dynavax.com

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Dynavax Technologies (LTS:0IDA) Headlines

No Headlines